Author

D. Dunham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Organism:bacteria (other)· 1 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

J. Gill· 1 shared K. Seed· 1 shared M. Manzano· 1 shared P. Viswanathan· 1 shared R. Oshiro· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 4 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

J. Gill

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The vibriophage-encoded inhibitor OrbA abrogates BREX-mediated defense through the ATPase BrxC

R. Oshiro, D. Dunham, K. Seed

This paper identifies how the phage-encoded inhibitor OrbA disrupts the BREX defense system in Vibrio cholerae by directly binding to the BrxC ATPase component.

bioRxiv · May 9, 2024Microbiology

Expression Ratios of the Anti-Apoptotic BCL2 Family Members Dictate the Selective Addiction of KSHV-Transformed Primary Effusion Lymphoma Cell Lines to MCL1

D. Dunham, P. Viswanathan, J. Gill, M. Manzano

This study shows that PEL cells depend on MCL1 for survival due to its higher expression compared to other BCL2 family members, and suggests caution in using MCL1 inhibitors as monotherapy.

bioRxiv · Sep 7, 2022Microbiology